$1.871
+0.006 (+0.31%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
XBIO Prediction & Forecast by Similar Chart Analysis
Alphio's XBIO stock price prediction model matches the current Xenetic Biosciences Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.93 (+3.38%). The 1-week path is $2.13 (+13.95%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Xenetic Biosciences Inc Stock?
Xenetic Biosciences Inc is not a good buy right now due to significant recent price declines and ongoing losses. The current price is $1.87, which is 62.14% below its 52-week high of $4.94, indicating a weak performance. Additionally, the RSI is at 34.674, suggesting that the stock is oversold, but this does not guarantee a rebound. The company reported a net loss of $0.46 million in Q1 2026, which is a continuation of its negative earnings trend, and the forward P/E ratio is currently at 0, indicating no expected earnings growth. The main risk is the recent merger announcement that caused a 48.71% drop in stock price, reflecting market concerns about the future direction of the company.
XBIO stock price ended at $1.87 on Friday, after rising +0.31%
Xenetic Biosciences Inc (XBIO) last closed at $1.8707, gaining +0.31%. These facts feed the 1-day and 1-week XBIO price prediction above.
Analyst Consensus
Xenetic Biosciences Inc (XBIO): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Xenetic Biosciences Inc (XBIO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches XBIO, ranked by similarity.
Seasonality analysis for XBIO
Historically the probability of a positive November return for XBIO is 45.45%. February offers the highest probability of a positive month at 74.14%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for XBIO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.62 | $3.04 | $3.42 | +62.74% |
| Dec 2026 | $2.77 | $2.99 | $3.09 | +59.59% |
In 2026, Xenetic Biosciences Inc (XBIO) is projected to range from $1.62 to $3.42.
Xenetic Biosciences Inc 2026 monthly forecast
In Nov 2026, Xenetic Biosciences Inc is projected to average $3.04, with a low of $1.62 and high of $3.42.
In Dec 2026, Xenetic Biosciences Inc is projected to average $2.99, with a low of $2.77 and high of $3.09.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.